Results 21 to 30 of about 2,200 (151)

The Management of Classical Hodgkin's Lymphoma: Past, Present, and Future

Advances in Hematology, 2011
The management of classical Hodgkin's lymphoma (CHL) is a success story of modern multi-agent haemato-oncology. Prior to the middle of the twentieth century CHL was fatal in the majority of cases.
S. E. Richardson, C. McNamara
doaj   +1 more source

Mediastinal Choriocarcinoma Masquerading as Relapsed Hodgkin Lymphoma

Case Reports in Oncology, 2011
Primary mediastinal choriocarcinoma is a rare extragonadal germ cell malignancy. We describe the first case of a patient who developed mediastinal choriocarcinoma after treatment for Hodgkin lymphoma (HL).
Selay Lam, Kamilia Rizkalla, Cyrus C. Hsia   +2 more
doaj   +1 more source

Targeted Drug Delivery of Anticancer Agents Using C₅N₂ Substrate: Insights from Density Functional Theory

Chemistry
Cancer has a threatening impact on human health, and it is one of the primary causes of fatalities worldwide. Different conventional treatments have been employed to treat cancer, but their non-specific nature reduces their therapeutic efficacy.
Syeda Huda Mehdi Zaidi, Muhammad Ajmal, Muhammad Ali Hashmi, Ahmed Lakhani   +3 more
doaj   +1 more source

Brentuximab Vedotin‐Induced Rash Sparing CD30‐Positive Mycosis Fungoides Lesions

JEADV Clinical Practice, EarlyView.
ABSTRACT Brentuximab vedotin (BV) is an effective treatment for CD30‐positive lymphomas, including mycosis fungoides (MF). However, its use can be associated with various cutaneous adverse effects, including rashes. This case describes a 60‐year‐old male with stage IIB MF who developed a drug‐induced erythematous rash after three infusions of BV ...
Isabel Hariri, Alexander H. Enk, Jessica C. Hassel   +2 more
wiley   +1 more source

Long‐Term Quality of Life in 1777 Persons With Hodgkin Lymphoma and 6166 Matched Comparators

American Journal of Hematology, Volume 101, Issue 7, Page 1654-1664, July 2026.
ABSTRACT Survival has improved substantially for patients with Hodgkin lymphoma (HL), but long‐term quality of life (QoL) remains incompletely understood. This was a Danish, nationwide, cross‐sectional study of QoL among persons with a diagnosis of HL matched 1:10 to general population comparators.
Sissel Johanne Godtfredsen, Joachim Baech, Mikkel Porsborg Andersen, Harman Yonis, Paw Jensen, Peter Kamper, Jacob H. Christensen, Rasmus Bo‐Dahl Sørensen, Martin Hutchings, Christian Torp‐Pedersen, Peter Sogaard, Henrik Boggild, Kristian H. Kragholm, Tarec C. El‐Galaly   +13 more
wiley   +1 more source

Role of Radiotherapy in Advanced Stage Hodgkin Lymphoma With Bulky Disease: A Systematic Review and Meta‐Analysis

eJHaem, Volume 7, Issue 3, June 2026.
ABSTRACT Background and Purpose: Hodgkin lymphoma (HL) is an uncommon malignancy predominantly affecting young adults. Chemotherapy is the main treatment, with radiotherapy used selectively in early‐stage disease. This meta‐analysis evaluates the impact of adding radiotherapy to bulky disease sites in advanced‐stage HL patients who achieve complete ...
Ahmad Masoud, Louai Alsaloumi, Ahmed Salem, Fanar Alsmarat, Mohammad Alsheikh, Jenan Alfayyoumi, Ftoon Abu Bader, Ranya Alsallal, Lujen Alelaimat, Zaid Daboubi, Rama Alkhatib, Salah Ibrahim, Abdelmomen Hassan   +12 more
wiley   +1 more source

DKK1 Targeting in Corneal Schwann Cells Rescues Axonal Regeneration and Mechanosensory Function After Corneal Injury

Journal of Neuroscience Research, Volume 104, Issue 6, June 2026.
The schematic illustrates that corneal injury imparted by a stromal incision or by toxic chemical exposure causes corneal Schwann cells (cSCs) and axons to degenerate rapidly, resulting in impaired mechanosensory function. We hypothesized that repair cSCs, which develop post injury, are an as‐yet‐untested cellular target for axonal regeneration.
Michael Li, Christian A. Tallo, Mary Katherine Eddy, Aarush Kolli, Ricky Paramo, Paola Bargagna‐Mohan, Royce Mohan   +6 more
wiley   +1 more source

Mechlorethamine Hydrochloride Gel in the Treatment of Mycosis Fungoides–Type Cutaneous T-Cell Lymphoma (MF-CTCL): A Focus on Patient Selection and Special Considerations

Cancer Management and Research, 2022
Caitlin Crimp,1 Ameya Gangal,2 Erica S Tarabadkar,3 Michi M Shinohara1,4 1Division of Dermatology, University of Washington, Seattle, WA, USA; 2School of Medicine, Emory University, Atlanta, GA, USA; 3Department of Dermatology, Emory University School of
Crimp C, Gangal A, Tarabadkar ES, Shinohara MM   +3 more
doaj  

Age‐Specific Gonadotoxic Alkylating‐Agent Exposure in Pediatric and Reproductive‐Age Females: A Claims‐Based Study Using Cyclophosphamide Equivalent Dose

Reproductive Medicine and Biology, Volume 25, Issue 1, January/December 2026.
ABSTRACT Purpose To describe age‐specific patterns of gonadotoxic alkylating‐agent exposure and evaluate how the cyclophosphamide equivalent dose (CED) framework captures real‐world exposure relevant to fertility preservation in females aged 0–43 years. Methods This descriptive study used a Japanese claims database.
Kentaro Taniguchi, Mizuki Ohashi, Yuji Tanaka, Tetsuro Hanada, Akie Takebayashi, Akimasa Takahashi, Tsukuru Amano, Shunichiro Tsuji   +7 more
wiley   +1 more source

Oncology drug repurposing as a blueprint for Alzheimer's therapy

Alzheimer's &Dementia: Translational Research &Clinical Interventions, Volume 12, Issue 1, January/March 2026.
Abstract Alzheimer's disease (AD) imposes substantial personal, social, and economic burdens, yet current therapies provide only modest slowing of clinical decline. Recent approvals of amyloid‐targeting antibodies confirm target engagement but also expose the limitations of single‐target strategies in a disease shaped by interacting processes ...
Viswanath Das, Marián Hajdúch
wiley   +1 more source